title: Gemcitabine-resistant pancreatic cancer: a second-line option.
authors.affiliation: Zentrum für Tumormedizin, 88045 Friedrichshafen, Germany. Electronic address: helmut.oettle@charite.de.
authors.forename: Helmut
authors.initials: H
authors.lastname: Oettle
authors.affiliation: Klinik für Allgemein- und Viszeralchirurgie, Klinikum Friedrichshafen, Friedrichshafen, Germany.
authors.forename: Thorsten
authors.initials: T
authors.lastname: Lehmann
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D021441:Carcinoma, Pancreatic Ductal / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D010190:Pancreatic Neoplasms / Q000188:drug therapy*